This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hyundai Pharm Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hyun-Hwa La: Innovator in GLP-1 Receptor Agonists
Introduction: Hyun-Hwa La is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of GLP-1 receptor agonists. His innovative work has the potential to impact the treatment of diseases associated with GLP-1 activity.
Latest Patents: Hyun-Hwa La holds a patent for a GLP-1 receptor agonist. The invention relates to a compound represented by Formula 1, wherein A, B, L, X, and Rto R are defined as described in the patent. This compound, or a pharmaceutically acceptable salt thereof, serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of diseases associated with GLP-1 activity. He has 1 patent to his name.
Career Highlights: La is currently associated with Hyundai Pharm Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.
Collaborations: Throughout his career, Hyun-Hwa La has collaborated with notable colleagues, including Han Kyu Lee and Jeong-Un Hwang. These collaborations have fostered a productive environment for innovation and research.
Conclusion: Hyun-Hwa La's contributions to the field of GLP-1 receptor agonists exemplify the impact of dedicated inventors in advancing medical science. His work not only enhances our understanding of GLP-1 activity but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile